Kyowa Hakko Kirin Plans Overseas Expansion As Global Specialty Pharma
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin President Nobuo Hanai said the company’s mid-term management plan starting next year includes policies to expand overseas with their antibody KW-0761.